“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about MannKind Corporation
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies dry-powder formulations and inhalation devices offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit mannkindcorp.com to learn more
| C-Level 5 | VP - Level18 |
| Director83 | Manager95 |
| Others173 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| mannkindcorp.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Compliance | Danbury, CT | calibration, e, testing, operating procedures, compliance, clean room, operations |
| Digital Transformation | Danbury, CT | calibration, e, testing, operating procedures, compliance, clean room, operations |
| Testing | Danbury, CT | calibration, e, testing, operating procedures, compliance, clean room, operations |
MannKind Corporation looking to hire in Account Payable in Danbury, CT
MannKind Corporation looking to hire in Application Development in Detroit, MI
MannKind Corporation looking to hire in Artificial Intelligence in Danbury, CT
Aws
Amazon connect
Cmms
Citrix
Collaborator
3d modeling
Agile
Acceptance testing
Access management
Ai-driven
At MannKind our employees are our number one asset, and we continue becoming a tight-knit communi...
View MoreWedbush analyst Yun Zhong maintained a Buy rating on MannKind today and set a price target of $11.00. Yun Zhong has given his Buy rating due to a
Read MoreWedbush analyst Yun Zhong maintained a Buy rating on MannKind today and set a price target of $11.00. Yun Zhong has given his Buy rating due to a
Read MoreMannKind Corporation (NASDAQ:MNKD) announced Tuesday the completion of its acquisition of scPharmaceuticals Inc., according to a statement filed with the
Read MoreMannKind ( ($MNKD) ) just unveiled an announcement. On October 7, 2025, MannKind completed the acquisition of scPharma, making it a wholly-owned subsidiary.
Read MoreMannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies dry-powder formulations and inhalation devices offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating...
Mannkind corporation operates in the Pharmaceutical manufacturing industry.
Mannkind corporation's revenue is $285.50m
Mannkind corporation has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.